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Abstract
Background: B lymphocytes are subject to elimination following strong BCR ligation in the absence of appropriate second
signals, and this mechanism mediates substantial cell losses during late differentiation steps in the bone marrow and
periphery. Mature B cells may also be eliminated through this mechanism as well as through normal turnover, but the
population containing mature cells destined for elimination has not been identified. Herein, we asked whether the
transitional 3 (T3) subset, which contains most newly formed cells undergoing anergic death, could also include mature B
cells destined for elimination.
Methodology/Principal Findings: To interrogate this hypothesis and its implications, we applied mathematical models to
previously generated in vivo labeling data. Our analyses reveal that the death rate of T3 B cells is far higher than the death
rates of all other splenic B cell subpopulations. Further, the model, in which the T3 pool includes both newly formed and
mature primary B cells destined for apoptotic death, shows that this cell loss may account for nearly all mature B cell
turnover.
Conclusions/Significance: This finding has implications for the mechanism of normal mature B cell turnover.
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Introduction
Following immunoglobulin (Ig) gene rearrangement and the
expression of a functional B cell receptor (BCR) (reviewed in [1–4])
in the bone marrow (BM), immature (IMM) B cells exit to the
periphery as transitional (TR) B cells, where they complete
maturation and then enter the follicular (FO) or marginal zone
(MZ) pools [5–8]. While the elimination of autoreactive B cells can
occur at any differentiative stage after functional BCR expression
[9–16], most tolerogenic death is believed to occur at the IMM
and TR stages, inasmuch as these are the first expressing a
functional BCR, and cells within these subsets seem predisposed to
BCR-induced death [11–12,15,17–18]. Consistent with this view,
in vivo labeling studies have revealed that under steady state
conditions, only about half a million of the roughly fifteen million
IMM BM B cells produced daily survive to join the mature
peripheral pools [19–20]. About 90% of these losses occur via
deletion at the IMM BM stage. The remaining losses occur
through anergic cell death, whereby cells engaged in low-avidity
interactions survive to enter the TR stages but die before
completing maturation [21–22].
The notion that anergic cells reside briefly in the TR
compartment before dying, as well as the belief that mature cells
are also subject to tolerogenic elimination if their BCR is engaged
without costimulation, prompts several questions. First, whether
particular TR phenotypes correspond to cells undergoing
apoptotic death versus those that will complete maturation is
unclear. Second, if particular phenotypes correspond to dying
cells, the proportional contributions of newly formed versus
mature cells to these pools require definition. Since mature B cells
are non-dividing, the relatively rapid turnover of TR pools
suggests that most losses in these subsets reflect the death of recent
marrow e ´migre ´s. Nonetheless, recent studies in transgenic systems
have suggested that FO cells dying from lack of costimulation re-
acquire the T3 phenotype [23], suggesting that this is character-
istic of cells undergoing anergic death, and implying that at least
some of the T3 pool is derived from mature B cells.
We have previously shown that mathematical modeling of
population kinetics established from in vivo bromodeoxyuridine
(BrdU) labeling studies is a powerful tool with which to assess
alternative models of B cell differentiation and fate [24–27]. Our
previous study of the population transitional B cells [26] has
compared all possible models which include the linear differen-
tiation pathway: bone marrow immature R T1 R T2 R T3 R
Follicular mature B cells. When set out to perform that study, the
exact progenitor–successor relationships of these transitional
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follicular B cell maturation, were controversial. Moreover,
whether late B cell differentiation might involve branched or
asynchronous maturation pathways, thus allowing some cells to
‘skip’ one or more of these stages, was also unknown. Hence, in
that study, we have used mathematical modeling to interrogate
these possibilities. Using mathematical models that numerically
simulate each model of splenic B cell population dynamics and fit
them to the experimental data, we have determined which models
best fit the in vivo labeling data. The results indicate that follicular
differentiation does not involve a proliferating splenic intermedi-
ate. Those same results further suggested that some developing
cells move directly from the immature marrow pool to more
advanced semi-mature peripheral subsets without passing through
the least mature subset in the spleen.
In the present study, we ask whether T3 B cell compartment
contains most peripheral B cell slated for elimination, and whether
a model based on this hypothesis (The inset in Figure 1) can
explain the quantitative relationship between T3 and mature B
cells. We addressed these questions by fitting our mathematical
models of B cell population kinetics in the BM and in the spleen
[25–27], implementing this new hypothesis of T3 behavior, to the
BrdU labeling data of Allman et al [28]. The results suggest that
the T3 B cell subset is a major staging point for B cells undergoing
apoptotic death, since this model can account for nearly all TR B
cell losses. Further, our analyses show that including input from
mature pools in the model yields a high fit for these data, with
,40% of T3 throughput derived from the mature B cell
population. Interestingly, this proportion could account for nearly
all mature B cell turnover under the normal steady state,
suggesting a common route and mechanism of loss from most
primary B cell subsets.
Methods
Data for Model Fitting
In order to understand the behavior of the transitional B cell
subpopulations that will become mature naive B cells in the
spleen, we used published experimental data on these subpop-
ulations in mice [28]. The data include measurements on four
subpopulations that are the three transitional B cell subsets and
the mature B cell subset in the spleen. Detailed methodological
descriptions are available in [19,28]. Briefly, mice were treated
with i.p. injections of 0.5 mg bromodeoxyuridine (BrdU)
(Sigma) twice daily. Splenocytes were analyzed at successive
intervals by immunofluorescent staining for surface markers and
incorporated BrdU. For each mouse, the percentage of BrdU-
labeled cells in each subset was measured using flow cytometry
and multiplied by the total cell number in the subset to give the
total number of labeled cells. The values were plotted as a
function of time.
Mathematical Models
Our model starts with three bone marrow populations: pro-B
[B220+CD43+IgM2], pre-B [B220+CD432IgM2] and imma-
ture B cells [B220+HSA+IgM
hiIgD
lo], with cell numbers in these
subsets represented by the variables Bo, Be and Bi, respectively.
However, previous experimental observations distinguish between
small, non-cycling cells and large, cycling cells in both the pro-B
and pre-B compartments, where the transition from pro-B to pre-
B occurs while the cells are cycling. Hence, we break the pro-B
and pre-B subsets into two subsets each: Bor for small resting pro-
B cells (Hardy’s fractions A through C) and Boc for large cycling
pro-B cells (part of Hardy’s fraction C); similarly, Bec for large
cycling pre-B cells (the remainder of fraction C) and Ber for small
resting pre-B cells (fraction D). Immature B (Bi) cells migrate from
the bone marrow to the periphery as transitional B cell. The four
subpopulations in the periphery are the three transitional B cell
subsets and the mature B cell subset in the spleen as defined by
Allman et al, [28], Table 1.
The numbers of cells in the T1 and T2 combined subsets, T3
and mature B cells were represented in our mathematical models
by the variables T1/2,T 3 and Bm. Bone-marrow cell populations
were described, as in our previous study [25], by the following
equations.
dBor
dt
~s{ dorzmo ðÞ Bor ð1Þ
dBoc
dt
~dorBorzcoBoc 1{
Bo
Ko
  
{docBoc ð2Þ
Figure 1. The alternative models of developing B cell populations in the spleen. The main figure shows the one found as the best model in
our previous study [28]. The new hypothesis differs from our previous model only in the direction of flow between T3 and mature B cells, as shown in
the inset. Cell subsets and parameters represented in our model are shown (see ‘‘Methods’’ for details).
doi:10.1371/journal.pone.0009497.g001
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dt
~docBoczceBec 1{
Be
Ke
  
{decBec ð3Þ
dBer
dt
~decBec{ mezder ðÞ BerzdrBi ð4Þ
dBi
dt
~derBer{ mizdrzdi ðÞ Bi ð5Þ
In these equations, the input of stem cells into pro-B
compartment is denoted by s (for ‘source’), the parameters d
denote differentiation rates and the parameters c denote
proliferation rates. Proliferation of developing B cells is known to
be limited by the finite space and resources (e.g. contact with the
stroma, growth factors, nutrients) in the bone marrow [29–30].
Hence Ko and Ke denote the carrying capacities of the pro- and
pre-B compartments, respectively, i.e. the population sizes for
which the corresponding population growth rates become zero.
Cell death is assumed in our model to occur only in the non-
proliferating cell subsets, because proliferation, gene rearrange-
ment and selection occur in distinct stages and cell death usually
occurs only as a result of failure in the latter two processes. The
corresponding population mortality rates are denoted by mo, me, mi
for Bor,B er,B i respectively. More information about this part of
the model is found in [25].
Immature B (Bi) cells migrate from the BM to the periphery with
a constant rate of di. Out of the diBi cells that exit the BM daily, f1
represents the fraction of these cells that differentiate to the T1/2
combined subset. There may also be a fraction, f3, of cells that
differentiate to T3, and a fraction, fm, of cells that differentiate to
Bm. T1/2 cells differentiate to T3 or to mature B cells (Bm). We
denote by d23 the differentiation rate of T1/2 to T3, and by d2m the
differentiation rate of T1/2 to Bm. Based on previous studies we
assumed that none of the transitional subpopulations are cycling
[28,26]. The exit/death rates from each compartment are denoted
by m1/2, m3, and mm for T1/2, T3 and Bm, respectively.
Finally, in the new model, no differentiation from T3 into Bm
is allowed. Instead, a differentiation from Bm into T3, denoted
by dm3, represents the new hypothesis that, when a mature
naive B cell does not get a second activation signal from T cell,
the cell then differentiates to the transitional 3 subset and
dies.
The above-described hypothesis is described by the following
equations.
dT1=2
dt
~dif1Bi{ d23zd2mzm2 ðÞ T1=2 ð6Þ
dT3
dt
~dif3Bizd23T1=2zdm3Bm{m3T3 ð7Þ
dBm
dt
~difmBizd1=2mT2{ dm3zmm ðÞ Bm ð8Þ
The numerical simulations of the mathematical models were
performed in a program written in the C programming language,
which runs on the entire parameter space in small intervals,
searching for the best-fit parameter set for each model.
Simulations
The mathematical models were simulated and fitted to data
using a C language program. The program receives as input the
experimental data, and the ranges of parameter values within
w h i c ht h em o d e ls h o u l db er u n .T h ep r o g r a md i v i d e se a c h
range to very small intervals, thus providing a thorough
coverage of the parameter space. This creates a set of
1.5610
6 parameter combinations to be checked by the
program. For each parameter value set, the program integrates
the model equations as follows. The initial conditions are zero
cells in all populations; labeling starts after the populations have
reached a steady state. After integration, the program first
checks whether the total cell number and the fractions of cells in
each population are within the experimentally measured ranges.
Runs in which this is not the case are discarded. For all other
runs, the program records the value of the fit of the model to the
data (defined below), and outputst h ep a r a m e t e rs e t ( s )t h a th a v e
yielded the best fit. This process was performed for each of the
models, and the fit values were compared using the AIC method
(see below).
Table 1. Post BCR-expression developmental subsets.
Anatomic Site Status Subset Cycling? Surface Phenotype
Bone marrow* Immature E no IgM
hiIgD
loCD23
+/2B220
+AA4.1
+
Periphery Transitional [28] T1 no IgM
hiCD23
2B220
+AA4.1
+
T2 no IgM
hiCD23
+B220
+AA4.1
+
T3 no IgM
loCD23
+B220
+AA4.1
+
Transitional [33] T1 no IgM
hiCD23-B220
+IgD
2CD21
2HSA
hi
T2 yes IgM
hiCD23
+B220
+CD21
hiIgD
loHSA
hi
Mature FO/(B2) no IgM
loCD23
+B220
hiAA4.1
2
Marginal Zone(MZ) CD9
+IgM
hiIgD
loCD23
2CD21
+
B1 IgM
hiCD43
+IgD
lo/2CD23
lo/2
* This is the current accepted phenotype for immature B cells. Because we used historic data for these analyses, we felt it appropriate to indicate in the text the criteria
used in the actual labeling studies, that is, B220+HSA+IgM
hiIgD
lo. It should be noted that this is unlikely to influence our conclusions, since the pro B subsets are not an
immediate progenitor pool to any subsets that might enter the T3 pool, regardless of which model is used.
doi:10.1371/journal.pone.0009497.t001
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In choosing alternative models and parameter values for the
simulations of our model, we adhered to the following guidelines.
(i) The parameters should be in the experimentally observed
orders of magnitude, if published information is available.
While these estimates (where available) are usually not given
in units of population rates, so that interpretation of most of
these data depends on the model used, these estimates were
useful in suggesting the appropriate value ranges for some of
the parameters. For example, cell proliferation rates can not
be higher than the equivalent of 3–4 divisions per day.
(ii) The steady state values obtained using these parameters
should be in agreement with our experimental observations
on both the total numbers and the composition of BM and
transitional B cells. Any parameter set which did not
conform to these criteria was automatically rejected.
(iii) The time of arrival to the steady state should be biologically
reasonable. That is, since a mouse completes its growth
within less than 2 months, parameter sets that resulted in
longer times of arrival to the steady state in each
subpopulation were also rejected.
These conditions significantly constrain the choice of parameter
ranges used in our simulations, such that the parameter subspace
which gives results obeying all constraints is rather narrow.
Model Fitting to the Experimental Data
Our goal here was to check whether the new hypothesis of T3
behavior accounts for B cell dynamics in the spleen), and estimate
the parameter ranges characterizing B cell dynamics in the spleen,
by fitting simulations to the published data described above.
Among all simulations that obeyed the above criteria, we looked
for the best fit to the experimental data, defined as the minimum
value of the sum of squared deviations of simulated points from
experimental data points (a least-squares fit), described by:
X 2
k~1
X T
t~1
Ykt{fkt
   2 ð9Þ
Ykt refers to the set of experimental measurements, fkt refers to
the set of simulation results, and these were compared for the two
populations (T3 and mature B cells), indexed by k, at each time
point t for which there was an experimental result.
Thus, we searched for parameter values that minimize the
deviation of results from experimental data, based on the least-
squares criterion defined above. Each automated search involved
varying all the relevant parameters simultaneously in very small
steps (0.01, or smaller if higher resolution was found to be
necessary), recording the fit of each run, and the parameter ranges
which gave results within the experimental errors. In order to find
whether the model fits the data, we conducted similar searches
over all biologically reasonable parameter ranges [24–27] for each
subpopulation, T1/2, T3 and the mature B cells, and calculated the
fit of those three subpopulations together.
We used ‘‘Akaike’s Information Criterion’’ (AIC) to find if our
model is more likely to give a good explanation of B cell
development in the spleen. We used an adaptation of the AIC
method. In this method, we associate an AIC score to the
parameter set that minimize the deviation of results from
experimental data. We denote M to be the number of parameters
fit by the regression, and N to be the number of data points. The
AIC score (corrected for small numbers of data points) is thus
defined by equation 10.
AICc~N ln
SS
N
  
z2Mz
2MM z1 ðÞ
N{M{1
ð10Þ
Suppose AICc(A) is the score of one with the minimal the
deviation of results from experimental data (SSA), and AICc(B) is
the score of another set of parameters with a minimal sum SSB.I n
this case, the difference between the AICc scores is given by
equation 11, and is has a negative value, since
SSA
SSB
v1.
DAIC~N ln
SSA
SSB
  
ð11Þ
The probability that we have chosen the correct model (out of
those that were considered) is then computed from equation 12.
Since we have used the sum of squared deviations as an
approximation for the MLE assumed by the AIC criterion, this
probability is an approximation.
P~
e{o:5DAIC
1ze{o:5DAIC ð12Þ
Results
The T3 Pool Represents Both Newly Formed and Mature
B Cells Undergoing Anergic Death
Our previously described mathematical models of B cell
development in the BM [25,27] and spleen [26] were used here,
but the T1 and T2 B cells were combined into a single subset,
because the differences between these two subsets are not
important for this study. We later verified that repeating the
model fitting to data without combining these 2 subsets gives the
same results (not shown).
Our model starts with three bone marrow populations: pro-B
[B220
+CD43
+IgM
2], pre-B [B220
+CD43
2IgM
2] and immature
B cells [B220+HSA+IgM
hiIgD
lo], with cell numbers in these
subsets represented by the variables Bo,B e and Bi, respectively.
However, previous experimental observations distinguish between
small, non-cycling cells and large, cycling cells in both the pro-B
and pre-B compartments, where the transition from pro-B to pre-
B occurs while the cells are cycling. Hence, we break the pro-B
and pre-B subsets into two subsets each: Bor for small resting pro-B
cells (Hardy’s fractions A through C) and Boc for large cycling pro-
B cells (part of Hardy’s fraction C); similarly, Bec for large cycling
pre-B cells (the remainder of fraction C) and Ber for small resting
pre-B cells (fraction D). Immature B (Bi) cells migrate from the
bone marrow to the periphery as transitional B cell. The four
subpopulations in the periphery are the three transitional B cell
subsets and the mature B cell subset in the spleen as defined by
Allman et al, [28], Table 1.
In our previous study, we showed that out of 630 possible
alternative models, only 8 can explain the population dynamics of
transitional B cell differentiation in the spleen [26]. All those
modes included the assumption that cells within the T3 subset
differentiate into mature B cells; the opposite possibility was not
tested in that study. In the present study, we used our previous
models of BM (equations 1–8) and spleen populations, but
T3: A B Cell Death Niche
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that T3 subset is characteristic of cells undergoing anergic death,
and that at least some of the T3 pool is derived from mature B
cells. In order to lower the number of degrees of freedom of the
parameter space, we combined T1 and T2 B cells into a single
subset, T1/2, which later differentiates to T3 and to mature B cells.
To examine the hypothesis that the T3 B cell compartment is the
phenotypic niche for cells undergoing negative selection, we ran
the equations of the model, in which the differentiation from the
mature to the T3 subset (with rate dm3) is added (The inset in
Figure 1).
We conducted simulations of this model, using the best set of
parameter values previously obtained for the BM equations, and
varying the parameters of the spleen populations, in order to
obtain the best fit to published experimental data on these
subpopulations in mice (section on data for model fitting and ref.
[28]).
The parameter value ranges for the new hypothesis are
presented in Table 2. These are the ranges of parameter values
that give results within the experimental range (i.e. the total cell
numbers in each population and the fractions of labeled cells
within each population are all within the experimental ranges)
(Figures 2 and 3). Note that the ranges given here are for each
parameter separately. Hence, not all values in the range given for
one parameter can necessarily be combined with all values in the
range given for other parameters to give acceptable results.
Using Akaike’s Information Criterion as described in the
methods shows that the probability that we have chosen the
correct model is 86%, hence the new hypothesis is more likely to
be correct.
We also obtained the same results with separate T1 and T2 B
cell subsets as with the combined subsets (data not shown). Thus,
we propose that mature naı ¨ve B cells undergoing death acquire T3
phenotypic characteristics.
An implication of this proposition is that most of the loss in
peripheral B cell maturation may be due to a high rate of loss in
the T3 B cell compartment. Indeed, in the parameter value sets
that gave the best fit, the death rate of T3 B cells was higher than
the death rate in all other splenic subpopulations. The value of the
death rate was at least one order of magnitude higher in T3 than of
mature B cells, and twice that of the T1/2 subpopulation (Table 2).
Therefore we can assume that the throughput of the T3 pool
Figure 2. Cell numbers versus time in a simulation of the
spleen population model. These numbers were obtained by a
simulation with the parameters set that gave the best fit to the data.
Parameter values are given in Table 2. The steady-state numbers are:
T1/2: 1.17610
6 cells, T3: 1.43610
6 cells, and Mature FO: 2.51610
6 cells.
doi:10.1371/journal.pone.0009497.g002
Figure 3. BrdU labeling kinetics. These kinetics were obtained by a
simulation of the spleen population model [25–26] with the parameter
set that gave the best fit to the data [28]. Parameter values are given in
Table 2. Simulation results (dashed lines) are presented along with the
experimental results (symbols with error bars).
doi:10.1371/journal.pone.0009497.g003
Table 2. Parameter ranges that result from the simulation.
Parameter symbol and description
a Value range in acceptable models
b Value in the best-fit model
f1- Fraction of differentiation from BM to T1/2 0.15–0.19 0.15
m2- Death rate of the T1/2 subset 0–0.1 0.05
f3- Fraction of differentiation from BM to T3 0–0.005 0
d23- Differentiation rate from T1/2 to T3 0.07–0.11 0.1
m3- Death rate of the T3 subset 0.13–0.19 0.17
fm- Fraction of differentiation from BM to mature B 0–0.009 0.004
d2m- Differentiation rate from T1/2 to mature B 0.035–0.06 0.05
dm3- Differentiation rate from mature B to T3 0.004 0.004
mm- Death rate of mature B cells 0–0.001 0
aRates are per 6 hours.
bModels that obey our parameter choice criteria and fit the experimental data.
doi:10.1371/journal.pone.0009497.t002
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cells.
Moreover, in the best-fit simulations, mature B cells differentiate
mostly from T1 and T2, both when we combined them (Table 2)
and when we modeled them separately (data not shown). This
suggests that T3 is rarely a developmental step in FO B cell
maturation. Rather, T3 is only a negatively selected subpopulation.
The Maximum Fraction of Mature B Cells That
Differentiate to the T3 Pool
We next proceeded to estimate the fraction of mature B cells
that differentiate to the T3 pool. The range of values of the
differentiation rate from mature B cells to T3 B cells (dm3) was
0.001–0.004 per 6 hours (Table 2). Multiplying the upper value of
this rate by the total number of mature B cells in steady state
(2.5610
7) in the spleen, we see that the maximum cell number in
the T3 pool that could represent recursion from mature B cells at
the steady state is around 10
5 T3 cells per 6 hours (Figure 4). The
best-fit value for the mature B cell death rate was zero, so the T3
pool likely contains the vast majority of peripheral B cells–
regardless of origin - destined for elimination.
The Best-Fit Model
In the previous study, several alternative models were found to
have a good fit to the data; all of them were models that included a
differentiation from T3 to mature B cells and not vice versa, but
they differed in the presence or absence of other transitions. For
example, we found that the T1 or the T2 stage, or both, may be
skipped by a small fraction of the differentiating cells. To find
whether all these possibilities are also valid in the new model, we
simulated all the alternative models of splenic B cell subsets that
include the new hypothesis. Whenever the existence or absence of
a certain transition was examined, the range of its rate parameter
included the possibility that this rate equals zero. This was applied
to f1,f 3,f m, d23, d23, and d2m. Our requirement that a model fit not
only the labeling kinetics of all splenic B cell subsets, but also the
total cell numbers, was used to reduce the number of acceptable
models.
As shown in Table 2, the value ranges for several of these
parameters that obey our above-described criteria and fit the
experimental data (section 2.4) included zero as a possible value.
Our new model fit of the experimental data better than all the
alternative models we found in our previous results [26]. The
parameter values for the best-fit model are shown in Table 2.
Again, the ranges given here are for each parameter separately,
and hence not all values in the range given for one parameter can
necessarily be combined with all values in the range given for other
parameters to give acceptable results. The equations of the best-fit
model are the following.
dT1=2
dt
~dif1Bi{ d23zd2mzm2 ðÞ T1=2 ð13Þ
dT3
dt
~d23T1=2zdm3Bm{m3T3 ð14Þ
dBm
dt
~difmBizd1=2mT2{dm3Bm ð15Þ
Thus, as shown in Figure 5, the best fit model contains the
possibility of some immature B cells ‘‘skipping’’ the peripheral
T1/2 stages and differentiating directly to mature B cells; T1/2 cells
may differentiate into either T3 or mature B cells; and, as
mentioned above, cell death in the mature B cell compartment is
negligible. The death rate in the T3 subset is highest, and this stage
is an end stage into which both T1/2 and mature B cells may be
directed.
Discussion
This study models the kinetics of splenic B cell compartments,
using a combination of in vivo BrdU labeling data [28] and a
mathematical model of B cell population dynamics [24–27]. Our
results suggest the T3 compartment represents a death niche for
peripheral B cells, and includes cells from both newly formed and
mature compartments undergoing apoptotic death. Thus, under
normal steady state conditions, up to 40% of the T3 pool could
represent entry from mature pools, with the remainder being
derived from newly formed cells. Finally, our analyses are most
consistent with a model in which most cells that enter the FO pool
do so from the T1 and T2 subsets directly.
We find that the in vivo labeling data are consistent with a
model in which the death rate among T3 B cells is higher than in
any other subpopulations, suggesting this pool represents the
principal death niche for peripheral B cells. The model predicts
that a majority of T3 B cells are derived from recent marrow
e ´migre ´s, confirming prior assumptions that the T3 subset contains
newly formed B cells that fail to meet the selective criteria imposed
during transitional differentiation [31–32]. Death during transi-
tional differentiation reflects either the failure to meet a minimum
tonic BCR signaling requisite or the onset of anergy from
sustained BCR cross-linking. Accordingly, our findings support a
model whereby the T3 pool follows a branch-point at which TR
cells destined for death versus final maturation have bifurcated
[31]. Indeed, the model suggests that the bulk of mature cells arise
from the T1/2 pools, with few, if at all, being rescued from the T3
subset [31–32].
Our analyses also reveal that up to 40% of the T3 pool, or about
10
5 T3 B cells, may be derived from the mature B cell
compartment. Because the mature pool is numerically large
compared to the T3 pool, this indicates a low overall frequency
Figure 4. The number of T3 B cells differentiating from the
mature compartment per time step. Here we plotted the mature B
cell differentiation term (dm3*Bm) in every time step (6 hours), obtained
by a simulation of the new hypothesis. The figure shows the steady
state that this number reaches within less than 2 months. Parameter
values are given in Table 2.
doi:10.1371/journal.pone.0009497.g004
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that nearly all mature B cell losses could proceed via this
phenotypic intermediate, because the mature B cell turnover of
,2% per day would generate a steady state value in the 10
5 range.
Thus, B cell losses in the T3 compartment can not only account for
all losses at the TR to mature B cell checkpoint, but can
accommodate the bulk of mature B cell turnover as well. This is
consistent with the view that T3 cells represent peripheral B cells
destined for death regardless of origin, in accord with recent
suggestions from Merrell et al [23].
Together, these findings suggest that B cells fated for imminent
elimination from pre-immune subsets comprise the T3 compart-
ment, where they reside briefly. It is tempting to speculate that this
reflects a common death pathway, especially since all of these cells
rely on continuous signaling via the BCR and BLyS receptor 3
(BR3, also termed BAFFR) to survive. Accordingly, failure to fall
within appropriate ranges for signaling via these two systems–
regardless of the basis - may lead to acquisition of the T3
phenotype and subsequent death.
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